Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?

Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has currently led to a global pandemic with millions of confirmed and increasing cases around the world. The novel SARS-CoV-2 not only affects the lungs causing severe acute respiratory d...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwesh, Ahmed M., Bassiouni, Wesam, Sosnowski, Deanna K., Seubert, John M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534795/
https://www.ncbi.nlm.nih.gov/pubmed/33031856
http://dx.doi.org/10.1016/j.pharmthera.2020.107703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534795/
https://www.ncbi.nlm.nih.gov/pubmed/33031856
http://dx.doi.org/10.1016/j.pharmthera.2020.107703

Ejemplares similares